Drug resistance and treatment failure in leishmaniasis: A 21st century challenge
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Drug resistance and treatment failure in leishmaniasis: A 21st century challenge
Authors
Keywords
Leishmania, Leishmaniasis, Parasitic diseases, Drug therapy, Leishmania donovani, Antimicrobial resistance, Antimony, Molecular epidemiology
Journal
PLoS Neglected Tropical Diseases
Volume 11, Issue 12, Pages e0006052
Publisher
Public Library of Science (PLoS)
Online
2017-12-15
DOI
10.1371/journal.pntd.0006052
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Laboratory confirmed miltefosine resistant cases of visceral leishmaniasis from India
- (2017) Saumya Srivastava et al. Parasites & Vectors
- Exploiting Knowledge on Leishmania Drug Resistance to Support the Quest for New Drugs
- (2017) Aya Hefnawy et al. TRENDS IN PARASITOLOGY
- Modulation of Aneuploidy in Leishmania donovani during Adaptation to Different In Vitro and In Vivo Environments and Its Impact on Gene Expression
- (2017) F. Dumetz et al. mBio
- Clinical and parasitological factors in parasite persistence after treatment and clinical cure of cutaneous leishmaniasis
- (2017) Alvaro J. Martínez-Valencia et al. PLoS Neglected Tropical Diseases
- Increased miltefosine tolerance in clinical isolates of Leishmania donovani is associated with reduced drug accumulation, increased infectivity and resistance to oxidative stress
- (2017) Deepak Kumar Deep et al. PLoS Neglected Tropical Diseases
- Sterol 14α-demethylase mutation leads to amphotericin B resistance in Leishmania mexicana
- (2017) Roy Mwenechanya et al. PLoS Neglected Tropical Diseases
- Single locus genotyping to track Leishmania donovani in the Indian subcontinent: Application in Nepal
- (2017) Keshav Rai et al. PLoS Neglected Tropical Diseases
- Genomic Appraisal of the Multifactorial Basis forIn VitroAcquisition of Miltefosine Resistance in Leishmania donovani
- (2016) P. Vacchina et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The LABCG2 Transporter from the Protozoan Parasite Leishmania Is Involved in Antimony Resistance
- (2016) Ana Perea et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Evidence of a drug-specific impact of experimentally selected paromomycin and miltefosine resistance on parasite fitness inLeishmania infantum
- (2016) S. Hendrickx et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Asymptomatic infection with American cutaneous leishmaniasis: epidemiological and immunological studies
- (2016) Fernando J Andrade-Narvaez et al. MEMORIAS DO INSTITUTO OSWALDO CRUZ
- Antimony to Cure Visceral Leishmaniasis Unresponsive to Liposomal Amphotericin B
- (2016) Gloria Morizot et al. PLoS Neglected Tropical Diseases
- Efficacy and Safety of AmBisome in Combination with Sodium Stibogluconate or Miltefosine and Miltefosine Monotherapy for African Visceral Leishmaniasis: Phase II Randomized Trial
- (2016) Monique Wasunna et al. PLoS Neglected Tropical Diseases
- Different Mutations in a P-type ATPase Transporter in Leishmania Parasites are Associated with Cross-resistance to Two Leading Drugs by Distinct Mechanisms
- (2016) Christopher Fernandez-Prada et al. PLoS Neglected Tropical Diseases
- Treatment of Cutaneous Leishmaniasis Caused by Leishmania aethiopica: A Systematic Review
- (2016) Johan van Griensven et al. PLoS Neglected Tropical Diseases
- Evolutionary genomics of epidemic visceral leishmaniasis in the Indian subcontinent
- (2016) Hideo Imamura et al. eLife
- Genomic and Molecular Characterization of Miltefosine Resistance in Leishmania infantum Strains with Either Natural or Acquired Resistance through Experimental Selection of Intracellular Amastigotes
- (2016) Annelies Mondelaers et al. PLoS One
- Experimental Resistance to Drug Combinations in Leishmania donovani: Metabolic and Phenotypic Adaptations
- (2015) Maya Berg et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Association of the Endobiont Double-Stranded RNA Virus LRV1 With Treatment Failure for Human Leishmaniasis Caused byLeishmania braziliensisin Peru and Bolivia
- (2015) Vanessa Adaui et al. JOURNAL OF INFECTIOUS DISEASES
- Presence ofLeishmaniaRNA Virus 1 inLeishmania guyanensisIncreases the Risk of First-Line Treatment Failure and Symptomatic Relapse
- (2015) Eliane Bourreau et al. JOURNAL OF INFECTIOUS DISEASES
- Arsenic Exposure and Outcomes of Antimonial Treatment in Visceral Leishmaniasis Patients in Bihar, India: A Retrospective Cohort Study
- (2015) Meghan R. Perry et al. PLoS Neglected Tropical Diseases
- Fitness of Leishmania donovani Parasites Resistant to Drug Combinations
- (2015) Raquel García-Hernández et al. PLoS Neglected Tropical Diseases
- Gene expression regulation in trypanosomatids
- (2015) Javier G. De Gaudenzi et al. Essays in Biochemistry
- Elucidation of Cellular Mechanisms Involved in Experimental Paromomycin Resistance in Leishmania donovani
- (2014) V. Bhandari et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Ascorbate Peroxidase, a Key Molecule Regulating Amphotericin B Resistance in Clinical Isolates of Leishmania donovani
- (2014) Ashish Kumar et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Leishmaniasis in immunosuppressed individuals
- (2014) J. van Griensven et al. CLINICAL MICROBIOLOGY AND INFECTION
- Failure of Miltefosine in Visceral Leishmaniasis Is Associated With Low Drug Exposure
- (2014) T. P. C. Dorlo et al. JOURNAL OF INFECTIOUS DISEASES
- Amphotericin forms an extramembranous and fungicidal sterol sponge
- (2014) Thomas M Anderson et al. Nature Chemical Biology
- Comparative transcript expression analysis of miltefosine-sensitive and miltefosine-resistant Leishmania donovani
- (2014) Arpita Kulshrestha et al. PARASITOLOGY RESEARCH
- Failure of Miltefosine Treatment for Visceral Leishmaniasis in Children and Men in South-East Asia
- (2014) Bart Ostyn et al. PLoS One
- Parasexuality and mosaic aneuploidy in Leishmania: alternative genetics
- (2014) Yvon Sterkers et al. TRENDS IN PARASITOLOGY
- Genome-Wide Stochastic Adaptive DNA Amplification at Direct and Inverted DNA Repeats in the Parasite Leishmania
- (2014) Jean-Michel Ubeda et al. PLOS BIOLOGY
- Visceral Leishmaniasis and HIV Coinfection in Latin America
- (2014) José Angelo Lindoso et al. PLoS Neglected Tropical Diseases
- Significantly Lower Anti-Leishmania IgG Responses in Sudanese versus Indian Visceral Leishmaniasis
- (2014) Tapan Bhattacharyya et al. PLoS Neglected Tropical Diseases
- Quantitative proteomic analysis of amphotericin B resistance in Leishmania infantum
- (2014) Marie-Christine Brotherton et al. International Journal for Parasitology-Drugs and Drug Resistance
- Candida tropicalis Antifungal Cross-Resistance Is Related to Different Azole Target (Erg11p) Modifications
- (2013) A. Forastiero et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- A New ABC Half-Transporter in Leishmania major Is Involved in Resistance to Antimony
- (2013) J. I. Manzano et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Increasing Failure of Miltefosine in the Treatment of Kala-azar in Nepal and the Potential Role of Parasite Drug Resistance, Reinfection, or Noncompliance
- (2013) Suman Rijal et al. CLINICAL INFECTIOUS DISEASES
- Miltefosine resistance in Leishmania donovani involves suppression of oxidative stress-induced programmed cell death
- (2013) Jyotsna Mishra et al. EXPERIMENTAL PARASITOLOGY
- Miltefosine-unresponsiveLeishmania donovanihas a greater ability than miltefosine-responsiveL. donovanito resist reactive oxygen species
- (2013) Mousumi Das et al. FEBS Journal
- (Post-) Genomic approaches to tackle drug resistance in Leishmania
- (2013) MAYA BERG et al. PARASITOLOGY
- Antimony-resistant but not antimony-sensitive Leishmania donovani up-regulates host IL-10 to overexpress multidrug-resistant protein 1
- (2013) B. Mukherjee et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Fitness Trade-offs Restrict the Evolution of Resistance to Amphotericin B
- (2013) Benjamin Matteson Vincent et al. PLOS BIOLOGY
- Efficacy and safety of single-dose liposomal amphotericin B for visceral leishmaniasis in a rural public hospital in Bangladesh: a feasibility study
- (2013) Dinesh Mondal et al. Lancet Global Health
- Single-dose liposomal amphotericin B: an effective treatment for visceral leishmaniasis
- (2013) Prabhat Kumar Sinha et al. Lancet Global Health
- Optimal Dosing of Miltefosine in Children and Adults with Visceral Leishmaniasis
- (2012) Thomas P. C. Dorlo et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Efficacy of Miltefosine in the Treatment of Visceral Leishmaniasis in India After a Decade of Use
- (2012) S. Sundar et al. CLINICAL INFECTIOUS DISEASES
- Miltefosine: a review of its pharmacology and therapeutic efficacy in the treatment of leishmaniasis
- (2012) T. P. C. Dorlo et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Amphotericin primarily kills yeast by simply binding ergosterol
- (2012) K. C. Gray et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Adaptive mechanisms in pathogens: universal aneuploidy in Leishmania
- (2012) An Mannaert et al. TRENDS IN PARASITOLOGY
- Prediction Score for Antimony Treatment Failure in Patients with Ulcerative Leishmaniasis Lesions
- (2012) Cristian Valencia et al. PLoS Neglected Tropical Diseases
- Sodium Stibogluconate (SSG) & Paromomycin Combination Compared to SSG for Visceral Leishmaniasis in East Africa: A Randomised Controlled Trial
- (2012) Ahmed Musa et al. PLoS Neglected Tropical Diseases
- Multiple Mutations in Heterogeneous Miltefosine-Resistant Leishmania major Population as Determined by Whole Genome Sequencing
- (2012) Adriano C. Coelho et al. PLoS Neglected Tropical Diseases
- Leishmania donovani Develops Resistance to Drug Combinations
- (2012) Raquel García-Hernández et al. PLoS Neglected Tropical Diseases
- Leishmania RNA virus: when the host pays the toll
- (2012) Mary-Anne Hartley et al. Frontiers in Cellular and Infection Microbiology
- Mechanism of Amphotericin B Resistance in Clinical Isolates of Leishmania donovani
- (2011) Bidyut Purkait et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Leishmaniasis chemotherapy—challenges and opportunities
- (2011) S.L. Croft et al. CLINICAL MICROBIOLOGY AND INFECTION
- Unusual Case of Resistance to Amphotericin B in Visceral Leishmaniasis in a Region in India Where Leishmaniasis Is Not Endemic
- (2011) P. Srivastava et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Comparison of short-course multidrug treatment with standard therapy for visceral leishmaniasis in India: an open-label, non-inferiority, randomised controlled trial
- (2011) Shyam Sundar et al. LANCET
- Safety and Efficacy of miltefosine alone and in combination with sodium stibogluconate and liposomal amphotericin B for the treatment of primary visceral leishmaniasis in East Africa: study protocol for a randomized controlled trial
- (2011) Raymond Omollo et al. Trials
- Visceral Leishmaniasis in the Indian Subcontinent: Modelling Epidemiology and Control
- (2011) Anette Stauch et al. PLoS Neglected Tropical Diseases
- Incidence of Symptomatic and Asymptomatic Leishmania donovani Infections in High-Endemic Foci in India and Nepal: A Prospective Study
- (2011) Bart Ostyn et al. PLoS Neglected Tropical Diseases
- Visceral Leishmaniasis and Arsenic: An Ancient Poison Contributing to Antimonial Treatment Failure in the Indian Subcontinent?
- (2011) Meghan R. Perry et al. PLoS Neglected Tropical Diseases
- Assessing aquaglyceroporin gene status and expression profile in antimony-susceptible and -resistant clinical isolates of Leishmania donovani from India
- (2010) S. Mandal et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- New World cutaneous leishmaniasis: Updated review of current and future diagnosis and treatment
- (2010) Panagiotis Mitropoulos et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Single-Dose Liposomal Amphotericin B for Visceral Leishmaniasis in India
- (2010) Shyam Sundar et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ambisome plus miltefosine for Indian patients with kala-azar
- (2010) Shyam Sundar et al. TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE
- Impact of poor-quality medicines in the ‘developing’ world
- (2010) Paul N. Newton et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Management of visceral leishmaniasis in rural primary health care services in Bihar, India
- (2010) E. Hasker et al. TROPICAL MEDICINE & INTERNATIONAL HEALTH
- Miltefosine in the Treatment of Cutaneous Leishmaniasis Caused by Leishmania braziliensis in Brazil: A Randomized and Controlled Trial
- (2010) Paulo R. Machado et al. PLoS Neglected Tropical Diseases
- Cellular Transport and Lipid Interactions of Miltefosine
- (2009) Gillian Barratt et al. CURRENT DRUG METABOLISM
- Gene expression modulation is associated with gene amplification, supernumerary chromosomes and chromosome loss in antimony-resistant Leishmania infantum
- (2009) P. Leprohon et al. NUCLEIC ACIDS RESEARCH
- Roles of Trypanothione S-Transferase and Tryparedoxin Peroxidase in Resistance to Antimonials
- (2008) S. Wyllie et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Characterization of an ABCG-Like Transporter from the Protozoan Parasite Leishmania with a Role in Drug Resistance and Transbilayer Lipid Movement
- (2008) E. Castanys-Munoz et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The Relationship between Leishmaniasis and AIDS: the Second 10 Years
- (2008) J. Alvar et al. CLINICAL MICROBIOLOGY REVIEWS
- Multilocus microsatellite typing (MLMT) reveals genetic homogeneity of Leishmania donovani strains in the Indian subcontinent
- (2008) M ALAM et al. INFECTION GENETICS AND EVOLUTION
- Paromomycin: Uptake and resistance in Leishmania donovani
- (2008) Anupam Jhingran et al. MOLECULAR AND BIOCHEMICAL PARASITOLOGY
- Modulation of gene expression in drug resistant Leishmania is associated with gene amplification, gene deletion and chromosome aneuploidy
- (2008) Jean-Michel Ubeda et al. GENOME BIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More